Extended Mesenteric Resection in Ileocecal Crohn's Disease.

Recruiting N/A Interventional Study
Crohn's Disease of Terminal Ileum
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
204 (estimated)
Sponsor
Odense University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The EXCEED project aims to study the role of the mesentery in disease recurrence in Crohn's disease (CD), as evidence suggests that including the mesentery when doing ileocecal resections can significantly reduce recurrence rates. The EXCEED study is a blinded randomised clinical trial with 204 participants having ileocecal Crohn's disease requiring resection. Participants will undergo either "sta…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria * Patients above the age of 18 scheduled for ileocecal resection due to Crohn's disease. * Relevant endoscopy and imaging within the last 6 months. * Diagnosis of "simple" ileocecal Crohn's disease (limited to ileocecal disease with a maximum of 40 cm of affected ileum). Exclusi…
Contacts

Jens K Bælum, MD

+4521758114

jens.kristian.baelum@rsyd.dk

CONTACT

Mark B Ellebæk, PhD

mark.ellebaek1@rsyd.dk

CONTACT